Insider Trading Alert - CMN, CIEN And EPAY Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 17, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $59.52 to $530,454,750.00.

Highlighted Stocks Traded by Insiders:

Cantel Medical (CMN) - FREE Research Report

Anaya Steven C, who is SVP; Chief Accounting Officer at Cantel Medical, sold 2,000 shares at $52.75 on June 17, 2015. Following this transaction, the SVP; Chief Accounting Officer owned 43,239 shares meaning that the stake was reduced by 4.42% with the 2,000-share transaction.

The shares most recently traded at $52.16, down $0.59, or 1.13% since the insider transaction. Historical insider transactions for Cantel Medical go as follows:

  • 4-Week # shares sold: 23,000
  • 12-Week # shares sold: 53,606
  • 24-Week # shares sold: 125,810

The average volume for Cantel Medical has been 124,500 shares per day over the past 30 days. Cantel Medical has a market cap of $2.2 billion and is part of the health care sector and health services industry. Shares are up 21.47% year-to-date as of the close of trading on Wednesday.

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. The stock currently has a dividend yield of 0.19%. The company has a P/E ratio of 48.7. Currently, there is 1 analyst who rates Cantel Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMN - FREE

TheStreet Quant Ratings rates Cantel Medical as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cantel Medical Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Ciena (CIEN) - FREE Research Report

Rothenstein David M, who is Sr. VP, General Counsel at Ciena, sold 1,500 shares at $25.39 on June 17, 2015. Following this transaction, the Sr. VP, General Counsel owned 254,621 shares meaning that the stake was reduced by 0.59% with the 1,500-share transaction.

The shares most recently traded at $26.05, up $0.66, or 2.53% since the insider transaction. Historical insider transactions for Ciena go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 4,900
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 44,910
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 83,427

The average volume for Ciena has been 3.2 million shares per day over the past 30 days. Ciena has a market cap of $3.0 billion and is part of the technology sector and telecommunications industry. Shares are up 31.94% year-to-date as of the close of trading on Wednesday.

Ciena Corporation provides equipment, software, and services that support the transport, switching, aggregation, service delivery, and management of voice, video, and data traffic on communications networks worldwide. Currently, there are 12 analysts who rate Ciena a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CIEN - FREE

TheStreet Quant Ratings rates Ciena as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Ciena Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Bottomline Technologies (EPAY) - FREE Research Report

Kelly John Francis, who is GM, Legal Solutions at Bottomline Technologies, sold 445 shares at $28.12 on June 17, 2015. Following this transaction, the GM, Legal Solutions owned 55,469 shares meaning that the stake was reduced by 0.8% with the 445-share transaction.

The shares most recently traded at $28.61, up $0.49, or 1.71% since the insider transaction. Historical insider transactions for Bottomline Technologies go as follows:

  • 4-Week # shares sold: 3,154
  • 12-Week # shares sold: 20,554
  • 24-Week # shares sold: 117,881

The average volume for Bottomline Technologies has been 158,600 shares per day over the past 30 days. Bottomline Technologies has a market cap of $1.2 billion and is part of the technology sector and computer software & services industry. Shares are up 15.51% year-to-date as of the close of trading on Wednesday.

Bottomline Technologies (de), Inc. provides cloud-based payment, invoice, and digital banking solutions to banks, corporations, insurance companies, and financial institutions worldwide. Currently, there are 5 analysts who rate Bottomline Technologies a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EPAY - FREE

TheStreet Quant Ratings rates Bottomline Technologies as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. Get the full Bottomline Technologies Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Trade-Ideas: Cantel Medical (CMN) Is Today's Strong And Under The Radar Stock

Trade-Ideas: Cantel Medical (CMN) Is Today's Strong And Under The Radar Stock

Cantel Medical's New CEO Jorgen B. Hansen to 'Close a Couple of Deals' in 'Near Future'

Cantel Medical's New CEO Jorgen B. Hansen to 'Close a Couple of Deals' in 'Near Future'

Today's Strong And Under The Radar Stock: Cantel Medical (CMN)

Today's Strong And Under The Radar Stock: Cantel Medical (CMN)

Insider Trading Alert - CMN, ASFI And HNRG Traded By Insiders

Insider Trading Alert - CMN, ASFI And HNRG Traded By Insiders

Cantel Medical (CMN) Highlighted As Strong And Under The Radar Stock Of The Day

Cantel Medical (CMN) Highlighted As Strong And Under The Radar Stock Of The Day